Drug Diversion Insights with Terri Vidals cover art

All Episodes

Drug Diversion Insights with Terri Vidals — 169 episodes

#
Title
1

The Safest Pharmacy Is the One That Talks About It

2

Upstream of Diversion: Pain, Mental Health, and the Making of a Substance Use Disorder

3

Less Burden, Better Compliance: Remote Drug Testing That Works for Facilities and Participants

4

Catching the Diversion Your Software Is Not Built to See

5

The Biggest Mistake Diversion Auditors Make

6

How to Define Significant Loss (When the DEA Won't) — Plus Building a Diversion Program Across a Health System

7

The Findings That Surprised Me: Three DEA Inspections, One Pharmacy Leader

8

What Can the US Learn From the UK's Approach to Drug Diversion?

9

No Software, No Problem: Directed Audits That Actually Catch Diversion

10

Borrow, Don't Build: A National Peer Support Toolkit for Healthcare Organizations

11

The Diversion Blind Spot Nobody Is Auditing

12

Saving a Million Lives: Dr. Paul Lynch on Rethinking Chronic Pain and Addiction

13

Caught in the Crossfire: When Trusted Colleagues Divert

14

Your Greatest Asset: How to Make Staff Your Eyes and Ears in Diversion Prevention

15

From Deception to Recovery: Why Healthcare Needs a Culture of Self-Reporting

16

No Software? No Problem—Conducting Effective Audits

17

42 to Near Zero: A QI Approach to Anesthesia Drug Discrepancies

18

Stop the Swap: Why “Integrated Waste” Is the Gold Standard for Controlled Substances

19

Buprenorphine Deep Dive: Neuroscience, Safety, and Clinical Decision-Making

20

CS Drips: Why Every Handoff Counts in Spotting Diversion

21

Buprenorphine Unfiltered: Efficacy, Discontinuation, and Post-Acute Withdrawal

22

Med Admin Basics: A Foundation of Diversion Mitigation

23

When Careers Hang in the Balance: Interviewing Healthcare Professionals Suspected of Diversion

24

Beyond the License: What Actually Matters in Diversion Program Leadership

25

The Propofol Problem: Why This Non-Controlled Substance Still Demands Your Attention

26

Securing the Unsecured: A Mayo Clinic Study on Propofol Disposal and Diversion Mitigation

27

How Controlled Substance Waste Impacts Pharmacy Teams

28

Anticipatory Compounding: Navigating the FDA-DEA Divide in Hospital Pharmacies

29

Culture First, Compliance Second: Rethinking Drug Diversion Prevention

30

Building Better Foundations: Essential Prep Work for Effective Diversion Monitoring

31

Behind the Survey: Former Surveyors for The Joint Commission Share What They Really Look for in Diversion Prevention Programs

32

Red Flags in ADM Cancel Transactions – What Auditors Need to Know

33

Beyond Poor Practice: How to Decide When Suspicious Activity Warrants a Formal Investigation

34

Inside the OR: An Anesthesiologist's Perspective on Medication Security and Diversion Prevention

35

Milk of Amnesia: The Joint Commission Insights on Propofol Security

36

Healing Through Stories: WisPAN Launches Their Podcast to Support Nurses in Recovery

37

What Rxpert Solutions Actually Does – A Behind-the-Scenes Look at Our Services

38

How to Build a Robust Diversion Program | Real Strategies, Leadership & Innovation in Healthcare

39

Speaking Out Safely: Legal Considerations for Healthcare Professionals Sharing Recovery Stories

40

Data Without Dialogue: A Dangerous Shortcut in Diversion Investigations

41

Missing from the Table: Infection Prevention's Role in Diversion Response

42

Beyond Diversion: Understanding Medical Record Falsification in Healthcare

43

The Art of Investigative Interviewing: Insights from a Healthcare 'Unicorn'

44

Protecting Your Practice: A Compliance Expert's Guide to Corresponding Responsibility

45

New Hires Surprised by Controlled Substance Accountability

46

Industry Shakeup: Bluesight's Acquisition of Protenus and What It Means for Customers

47

A Compassionate Approach to Neonatal Abstinence Syndrome: Conversation with Tara Sundem

48

Confronting the Hidden Costs of Medication Waste in Hospital Settings

49

When Surveyors Dig Deeper: The Shift Toward Meaningful Diversion Programs

50

Healthcare Tech Evolution: Bluesight's Growth and Vision for Diversion Monitoring

51

Telemedicine Buprenorphine: Expanding Access to Opioid Use Disorder Treatment

52

Legal Preparedness in Healthcare: A Conversation with Ronald Chapman II

53

Minding Our Own Store: Pharmacy-Based Drug Diversion

54

Cross-Border Perspectives: Drug Diversion in Canadian Healthcare

55

When the Healer Needs Healing: A Doctor's Path to Recovery

56

The Sweet Connection: Linking Sugar and Drug Use Disorders

57

Optimizing Controlled Substance Waste: Research Insights from the Field

58

Christie Moon on Balancing Compliance, Employee Rights & Safety in Drug Diversion Investigations

59

Legacy of Leadership: A Conversation with IHFDA's John Burke

60

Revolutionizing Drug Testing: DNA Verification, Rapid Results, and Fentanyl Detection

61

From the Front Lines to the C-Suite: Nursing Leadership, Diversion Crises, and Battling Burnout

62

Healing the Healers: Inside South Dakota's Health Professionals Assistance Program

63

Beyond Debriefing: Exploring COMPASS and Support for Healthcare Professionals

64

Addressing Drug Diversion: A Conversation with a Compliance Expert

65

Closing the Gap in Medication Waste: How MIDAS View Adds a Critical Tool to Mitigate Drug Diversion

66

Navigating the World of Diversion Prevention: Insights from the Frontlines

67

Revolutionizing Healthcare: Wolters Kluwer's Acquisition of Invistics Flowlytics Diversion Software

68

Exploring Drug Courts with Judge Jose Salinas

69

Insights from a Psychiatric Nurse Leader on Substance Management and Ambulatory Care Challenges

70

Beyond the Error: Uncovering Impairment in Safety Events with Patches Seely

71

Dueling Detection: 3rd Party vs. In-House Automation in Diversion Monitoring

72

Collaborative Defense: Nurses & Pharmacists United Against Diversion

73

Supporting Physician Recovery with PHPs

74

Finding Balance: A Holistic Approach to Substance Use Disorder Recovery with Joseph Eisele

75

Protecting Patients, Empowering Professionals: Inside the Indiana Professional Recovery Program

76

Returning to Practice, Safeguarding Patients: South Carolina's Recovering Professionals Program

77

Personal Journey and Legal Lessons

78

Facing a Nursing License Complaint? Protect Yourself with Knowledge and Advocacy

79

Navigating the Maze: The ADA and its Implications for Healthcare Diversion Investigations

80

Beyond Nursing School: Unveiling the Truths Nurses Need to Know

81

Prescription and Prejudice: Breaking the Stigma of MAT in Healthcare

82

How Recovery Monitoring Agreements Shape Second Chances

83

Should a Healthcare Professional Self Report Diversion to their Licensing Board?

84

Tips on How to Perform a Behavioral Interview from Pharmacists with a Badge

85

A Resource All States Should Strive For

86

Is Residual Waste a Diversion Risk?

87

Let's Change the Way Healthcare Professionals Handle Repetitive Daily Stressors

88

Caduceus: A Support Group for Health Care Professionals in Recovery

89

Recovery Program for Licensed Healthcare Professionals in Massachusetts

90

What Differentiates Imprivata's Diversion Surveillance Software from the Others

91

Is Your Diversion Education Meaningful?

92

Hands On Approach to Monitoring for Diversion

93

An Overview of Drug Diversion Software from LogicStream

94

Journey to a Substance Use Disorder

95

Using Biometric Data to Improve Recovery Outcomes

96

Diversion Mitigation Starts Before an Order is Ever Written

97

Words of Wisdom From a Defense Attorney

98

Substance Use Disorders and Barriers to Treatment

99

Recovery Program for Licensed Healthcare Professionals in Michigan

100

Diversion Programs in Rural Settings

101

Possible Victim of Diversion

102

The DEA and Patient Own Meds

103

How Prepared is Your Facility for a Visit from the DEA?

104

Adjusting Interview Style to Meet the Circumstances

105

A Look Inside DEA Investigations

106

Ransomware and Controlled Substance Security

107

Recovery Program for Licensed Healthcare Professionals in California

108

When to Report to the FDA

109

History and Elimination of the DATA Waiver

110

From Manual to Automated

111

Avera Health's Successful Reintegration Program

112

Do Pediatric Hospitals Have Unique Diversion Challenges?

113

Applying the Just Culture Algorithm to Suspected Diversion

114

The Value of Peer Support Groups to Recovery

115

What Does a Healthy Recovery Program Look Like?

116

Why is Drug Diversion a Patient Safety Issue?

117

24 Years and Counting, A Success Story in the OR with Bridget Petrillo, CRNA

118

An Anesthesiologist's Perspective with Keith Berge, MD Anesthesiologist, Retired

119

Great Interview Takeaways with Denzil Lewis, Corporate Investigator for Community Health

120

UCHealth Diversion Program Triad

121

Humanizing Substance Use Disorders

122

Aaron A. Reed, DNP Founder of Focused Solutions Advocate, LLC

123

A Controlled Substance Pot Pourri Discussion

124

Different Perspective on Conducting an Interview

125

Another Tool for your Diversion Monitoring Toolkit

126

Total Well Being With the Chief Ikigai Officer of Connect3x

127

Incorporating Patient Interviews into an Investigation

128

Thoughts on Peer Group Support, Reintegration, and Interviewing

129

Waste Assaying in a Large Health System

130

Drug Testing

131

Results of a Workflow Study Time of Controlled Substance Waste

132

Jake Nichols Pharmacist in Long-term Recovery

133

CAREDirect Has an Access Control Solution for Small to Mid-size Entities

134

RxDestruct - Next Generation Pharmaceutical Waste Management

135

From Feeling Better Than Ever to Post Acute Withdrawal Syndrome

136

Benefits of a Drug Diversion Task Force

137

One Institution's Diversion Software Selection Process

138

The Drug Diversion Triad with Maureen Burger, Chief Nursing Officer at Visante

139

Cameras in the Operating Room

140

Cal Hospital Compare Opioid Care Honor Roll

141

Interview with Medacist President & CEO, David Brzozowski

142

Interview with Anigent Chief Product Officer & Managing Partner Charles D'Amato

143

How Does it Feel Knowing You May have Diversion in Your Unit - A Supervisor's Perspective

144

Joseph Buckley President of John E. Reid and Associates

145

Interview with a Scott Lamp, a Pharmacist with a Badge

146

How One Nurse's Struggles Can Work Toward Destigmatizing Substance Abuse and Help Other Healthcare Professionals on the Road to Recovery

147

First Hand Experience with Addiction and Recovery Through the Eyes of a Colleague and Loved One

148

A Conversation with Samantha Roberts, Controlled Substance Program Manager with Emory Healthcare

149

Healing Through Fasting and Healthy Eating with Dr. Alan Goldhamer

150

COVID and its Impact on Drug Addiction with Rigo Garcia

151

A Look at Pharmacolog and Their Products in the Diversion Monitoring Space

152

A Look at PharmID and Their Products in the Diversion Monitoring Space

153

Dr. Nathan Painter and the San Diego Prescription Drug Abuse Task Force

154

Rodrigo Garcia on Creating a Culture of Self Reporting

155

"Don Teater MD, MPH Pain and addiction specialist Martha Teater MA Therapist"

156

The Interview/Interrogation Process with Russ Nix

157

Interview with Nick Culbertson, CEO & Co-Founder of Protenus

158

Interview with Rodrigo Garcia, CEO of Parkdale Center

159

Simulations and Networking with Heidi McNeely

160

Interview with Tom Knight on HealthCareDiversion.org

161

Interview with Charlie Cichon, Executive Director of NADDI

162

Trauma and Predisposition to Pain and Addiction, Interview with Dr. Don and Martha Teater

163

Russ Nix on the Importance of Policies and Procedures

164

Identification & Development of a Diversion Program with Mary Nelson

165

A Story of Recovery and Hope with Dawn Reese

166

Stigma Associated with Addiction, Interview with Dr. Don and Martha Teater

167

An inside look at Flowlytics with Xing Guan

168

Interview with John Burke, Co-Founder and President of IHFDA

169

Interview with Russ Nix, Founder of Aegis RX